Wockhardt reports a 24% increase in Q2 revenue, reaching ₹939 crore, but net profit drops as the company invests heavily in its new antibiotic Zaynich. Discover the impacts on profit margins and ...

Gland Pharma has named Ajay Sahni as the new CEO of its Singapore subsidiary, Gland Singapore, effective November 2, 2026.

Sanofi is set to pursue larger acquisitions and enhance its growth strategy under the leadership of CEO Belen Garijo, aiming ...

Fresenius has entered a major development agreement with WuXi Biologics to enhance its biosimilars pipeline, targeting a market worth over €370 billion. This partnership aims to boost Fresenius’ ...

Senores Pharmaceuticals has announced its Q2 FY27 financial results, showcasing a 25% increase in revenue to ₹192 crore, ...

Granules India receives a form 483 from the FDA with 11 observations during inspection, highlighting process and ...

India's pharmaceutical industry has experienced unprecedented double-digit growth over the past four quarters, driven mainly ...

Laurus Labs expands its capabilities in the oligonucleotide and peptide sectors with strategic acquisitions, enhancing R&D, ...

A Delhi court discharges former Joint Drugs Controller Dr. S. Eswara Reddy and three others in a bribery case involving ...

The Union Health Ministry of India has revised the shelf life requirements for imported drugs, adjusting from 60% to a ...

AbbVie raises its profit forecast following strong Q3 results, driven by rising demand for immunology and neuroscience drugs like Skyrizi and Rinvoq, offsetting Humira's declining sales.